All About Multiple Sclerosis

More MS news articles for February 2004

Immunomonitoring measures in relapsing-remitting multiple sclerosis

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14975601&dopt=Abstract

J Neuroimmunol. 2004 Mar;148(1-2):192-9
Matsui M, Araya SI, Wang HY, Matsushima K, Saida T.
Department of Neurology and Clinical Research Center, Center for Neurological Diseases, Utano National Hospital, Ukyo, Kyoto 616-8255, Japan.

Forty-five patients with relapsing-remitting multiple sclerosis (MS) were examined to determine intracellular cytokine profiles and the surface phenotype of circulating lymphocytes during active, recovery, and stable stages.

Active stage patients were characterized by decreases in CD4(+)IL-4(+) Th2 as well as CD4(+)IFN-gamma(+) Th1 cells, when compared with stable stage patients and 16 healthy controls.

CCR4(+) Th2 cells were persistently decreased at every MS stage as compared to the controls.

CD4(+)CD29(+) and CD4(+)CXCR3(+) cells were closely correlated with IFN-gamma-producing cells.

These findings suggest that simultaneous flow cytometry for these two types of measurements can provide information concerning current immune status in MS.